Cite Filings / AARD / 0001950047-25-007102
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
144

Sale of Securities

Aardvark Therapeutics, Inc. · Filed 2025-09-15 · Acc 0001950047-25-007102

Documents 1

  • 144 Sale of Securities , xsl144X01/primary_doc.xml

Around this filing

  • 2026-09-10 144 Sale of Securities
  • 2025-09-16 4 Chief Executive Officer bought 10,000 shares at an average $9.66 ($96,624)
  • 2025-09-15 144 Sale of Securities
  • 2025-09-12 4 Chief Executive Officer bought 20,000 shares at an average $8.03 ($160,654)
  • 2025-09-10 4 Chief Financial Officer bought 6,000 shares at $8.07 ($48,440)
  • 2025-09-02 144 Sale of Securities

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading xsl144X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…